A股異動 | 新易盛跌5% 目前公司800G光模塊產品仍處於小批量出貨階段
格隆匯5月19日丨新易盛(300502.SZ)跌5.37%,報69.79元,總市值354億元。新易盛5月18日公吿,公司近期關注到北美廠商更新800G光模塊需求規劃指引的相關傳聞,可能受此影響,公司股票交易價格與創業板綜合指數偏離較大。行業800G光模塊產品市場的整體需求規模以及公司800G光模塊產品的出貨進度仍存在較大不確定性,目前公司800G光模塊產品仍處於小批量出貨階段,近期可能對公司銷售收入和利潤帶來的影響也存在較大不確定性。公司無法保證上述傳聞的真實性。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.